A case of interferon alpha-induced manic psychosis in chronic hepatitis C

被引:12
作者
Kanno, A
Yamada, M
Abe, M
Okamoto, Y
机构
[1] Tohoko Koseinenkin Hosp, Dept Internal Med, Miyagino Ku, Sendai, Miyagi 9838512, Japan
[2] Tohoko Koseinenkin Hosp, Dept Neuropsychiat, Sendai, Miyagi 9838512, Japan
关键词
interferon; mania; hepatitis C;
D O I
10.1620/tjem.187.79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is well known that mood disorder such as depression occasionally develops during interferon (IFN) therapy for chronic viral hepatitis. So far, however, IFN-induced manic disorder has been rarely reported. We present a case of manic psychosis which developed during IFN treatment for chronic hepatitis C. A 35-year-old man with chronic hepatitis positive for hepatitis C virus RNA in serum was treated with natural IFN alpha with a daily dosage of 5 million units. Six weeks later he complained of insomnia, and then became exhilarated, talkative, restless and aggressive. Since the mental state was compatible with manic disorder, IFN therapy was immediately ceased. Simultaneously, psychotropic drugs were administered. One week later, the psychiatric disturbances disappeared. He has been beeping his usual social interactions without the psychotropic drugs after that. It is suggested that manic psychosis happened secondary to IFN alpha treatment. (C) 1999 Tohoku University Medical Press.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 13 条
[1]  
ADAM Z, 1994, ACTA MED AUST, V21, P137
[2]   HUMAN-LEUKOCYTE INTERFERON (HUIFN-ALPHA) - POTENT ENDORPHIN-LIKE OPIOID ACTIVITY [J].
BLALOCK, JE ;
SMITH, EM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (02) :472-478
[3]   INTERFERON ENHANCES THE EXCITABILITY OF CULTURED NEURONS [J].
CALVET, MC ;
GRESSER, I .
NATURE, 1979, 278 (5704) :558-560
[4]   A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon [J].
Fattovich, G ;
Giustina, G ;
Favarato, S ;
Ruol, A ;
Macarri, G ;
Orlandi, F ;
Iaquinto, G ;
Ambrosone, L ;
Francavilla, A ;
Pastore, G ;
Santantonio, MT ;
Romagno, D ;
Bolondi, L ;
Sofia, S ;
Marchesini, A ;
Pisi, E ;
Mazzella, G ;
Roda, E ;
Attaro, L ;
Chiodo, F ;
Mori, F ;
Verucchi, G ;
Lanzini, A ;
Salmi, A ;
Calvi, B ;
Bozzetti, F ;
Radaeli, E ;
Bernasconi, M ;
Pilleri, G ;
Bacca, D ;
Romano, G ;
Mastrapasqua, G ;
Cozzolongo, R ;
Cacopardo, B ;
Nunnari, A ;
Blasi, A ;
Sala, LO ;
Minoli, G ;
Sangiovanni, A ;
Spinzi, GC ;
Colombo, A ;
Camassa, M ;
Riva, D ;
Maggi, G ;
Boccia, S ;
Gualandi, G ;
Nucci, A ;
Pacini, F ;
Marino, N ;
Mazzotta, F .
JOURNAL OF HEPATOLOGY, 1996, 24 (01) :38-47
[5]  
HABIF DV, 1975, P SOC EXP BIOL MED, V149, P287
[6]   SUICIDE ASSOCIATED WITH ALFA-INTERFERON THERAPY FOR CHRONIC VIRAL-HEPATITIS [J].
JANSSEN, HLA ;
BROUWER, JT ;
VANDERMAST, RC ;
SCHALM, SW .
JOURNAL OF HEPATOLOGY, 1994, 21 (02) :241-243
[7]  
MCDONALD EM, 1987, LANCET, V2, P1175
[8]   PERSISTENT NEUROTOXICITY OF SYSTEMICALLY ADMINISTERED INTERFERON-ALPHA [J].
MEYERS, CA ;
SCHEIBEL, RS ;
FORMAN, AD .
NEUROLOGY, 1991, 41 (05) :672-676
[9]   Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: An overview of cases in Japan [J].
Nozaki, O ;
Takagi, C ;
Takaoka, K ;
Takata, T ;
Yoshida, M .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1997, 51 (04) :175-180
[10]   PSYCHIATRIC COMPLICATIONS OF LONG-TERM INTERFERON ALFA THERAPY [J].
RENAULT, PF ;
HOOFNAGLE, JH ;
PARK, Y ;
MULLEN, KD ;
PETERS, M ;
JONES, B ;
RUSTGI, V ;
JONES, A .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (09) :1577-1580